3rd Annual Québec Biotechnology Conference

Venue: NYSSA

Location: New York, New York, United States

Event Date/Time: Mar 20, 2007 End Date/Time: Mar 20, 2007
Registration Date: Mar 13, 2007
Early Registration Date: Mar 13, 2007
Report as Spam


As Americans’ ownership of securities has increased, so has their investment activity in foreign markets. From 1980 to today, U.S. activity (purchases and sales) in foreign securities has grown dramatically, from $53 billion to more than $7 trillion. For the first 9 months of 2006, purchase of foreign stocks totaled $145 billion, surpassing the $100 billion annual average from the mid-1990s through 2000.

Québec represents one of the most fertile sources of investment opportunity in biotechnology. A well-educated and relatively inexpensive labor-force, low cost of doing business, geographic proximity to many of the largest markets in North America, and generous research tax credits have enabled biotechnology companies from this region to excel in the world markets.

Learn about investment opportunities in some of the world’s most innovative and aggressive public biotechnology stocks. Hear CEOs, CFOs, and other VIPs from seven companies currently listed on the Toronto Stock Exchange and TSX Venture Exchange—each a leader in its category—discuss how they are using their favorable operating environment to gain market share and provide rewarding returns for their investors. The event is perfect for securities analysts, portfolio managers, hedge fund managers, institutional investors, venture capitalists, investment bankers, and other investors in biotechnology.


1177 Avenue of the Americas, 2nd Floor
New York
New York
United States